Assignee
IMAGO BIOSCIENCES INC
US·11 granted patents·11 pending applications·52 citations·filing 2014–2023
Top patents by PatentIndex Score
22 records- 0195US10519118B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2018·Granted Dec 31, 2019·8 cites·22 claims
- 0294US10882835B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 5, 2021·6 cites·14 claims
- 0393US11230534B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 25, 2022·4 cites·10 claims
- 0493US9981922B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2016·Granted May 29, 2018·11 cites·9 claims
- 0590US10370346B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2017·Granted Aug 6, 2019·7 cites·48 claims
- 0690US9790195B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2014·Granted Oct 17, 2017·10 cites·58 claims
- 0788US11655226B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2020·Granted May 23, 2023·1 cites·19 claims
- 0884US11578059B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Feb 14, 2023·2 cites·30 claims
- 0984US11390590B2Methods and processes for the preparation of KDM1A inhibitorsIMAGO BIOSCIENCES INC·Filed 2017·Granted Jul 19, 2022·3 cites·28 claims
- 1077US11773068B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2021·Granted Oct 3, 2023·0 cites·5 claims
- 1176US11932629B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Granted Mar 19, 2024·0 cites·21 claims
- 1271US2023104647A1Methods and processes for the preparation of kdm1a inhibitorsIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1366US2023000835A1Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1466US2026085082A1Kdm1a inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1564US2025288668A1Methods for the enhancement of therapeutic effect of car-t cellsIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1662US2021196711A1Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1762US2021386733A1Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1861US2025032454A1Kdm1a inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1960US2023293495A1Pharmaceutical formulations for treating diseases mediated by kdm1aIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2057US2026083729A1Methods for treatment of bone marrow failure and related conditionsIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2156US2019070172A1Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2243US2022025424A1Compositions and methods for producing stereoisomerically pure aminocyclopropanesIMAGO BIOSCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMAGO BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →